Nikhil Singh Data-verified

OverviewAI-generated summary

Nikhil Singh's research focuses on the clinical management of infectious diseases, particularly in immunocompromised patient populations. His work has explored the use and appropriateness of antimicrobial and antifungal agents in patients with neutropenia and cancer, as evidenced by his publications analyzing hospital prescribing survey data and developing audit tools. Singh has also investigated the application of fluoroquinolone prophylaxis in high-risk patients and contributed to guidelines for managing neutropenic fever. His research extends to understanding the prevalence of healthcare-associated and opportunistic infections in transplant and cancer patients, with a protocol for a point prevalence study. Additionally, Singh has examined pharmaceutical packaging issues impacting patients and investigated a specific case of pembrolizumab-associated sarcoidosis in a melanoma patient. He also has a publication on a whole-virion-inactivated B.1.617.2 vaccine candidate.

Metrics

• h-index: 7
• Publications: 30
• Citations: 375